Put companies on watchlist
MediClin AG
ISIN: DE0006595101
WKN: 659510
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

MediClin AG · ISIN: DE0006595101 · EQS - Company News (52 News)
Country: Germany · Primary market: Germany · EQS NID: 1450143
26 September 2022 02:03PM

MediClin AG: MEDICLIN plans to close the Schlüsselbad Klinik in Bad Peterstal by the end of 2022, subject to the outcome of the consultations with the works council


EQS-News: MediClin AG / Key word(s): Miscellaneous
MediClin AG: MEDICLIN plans to close the Schlüsselbad Klinik in Bad Peterstal by the end of 2022, subject to the outcome of the consultations with the works council

26.09.2022 / 14:03 CET/CEST
The issuer is solely responsible for the content of this announcement.


Offenburg, September 26, 2022

MEDICLIN plans to close the Schlüsselbad Klinik in Bad Peterstal by the end of 2022, subject to the outcome of the consultations with the works council

In its meeting on Friday, the Supervisory Board of MEDICLIN Aktiengesellschaft followed the proposal of the Management Board and the management of MEDICLIN GmbH & Co. KG to close the Schlüsselbad Klinik in Bad Peterstal at the end of 2022, subject to the outcome of the consultations with the works council.

MEDICLIN currently sees no way of continuing to operate the Schlüsselbad Klinik in Bad Peterstal with the required high quality of services in a cost-covering manner. In the opinion of the management bodies, the shortage of skilled workers, especially in the rural region, no longer allows for stable, sustainable further development combined with corresponding investments - the structural structure of the clinic is not sustainable. The already challenging situation of the clinic is exacerbated by an occupancy rate, which is still below the usual occupancy rate due to corona, the high costs caused by inflation and, since July 2022, the termination of protective shielding benefits. "I can assure you that we did not take the decision lightly," emphasises Dr. York Dhein. Member of the Management Board of MEDICLIN.

In the event of closure, MEDICLIN wants to find an amicable solution with the works council that considers the different interests of the employees.

"Our top priority is to continue the employment at other Group locations in the region," says Dr. York Dhein. "The employees of the Schlüsselbad Klinik have worked here for many years with a lot of commitment - we thank them very much for that!"

In the event of closure, patients will be offered suitable alternatives in other Group clinics, so that they can continue to receive treatment of the quality they are accustomed to.

About MEDICLIN Aktiengesellschaft (Ticker: MED; WKN: 659 510)

MEDICLIN includes 35 clinics, seven care facilities and eleven medical care centers. The Group has around 8,350 beds/care places and employs around 10,200 people. In a strong network, MEDICLIN offers the patient integrative care from the first visit to the doctor through the operation and subsequent rehabilitation to outpatient aftercare. Doctors, therapists and nurses work together in a carefully coordinated manner. MEDICLIN designs the care and support of people in need of care according to their individual needs and personal needs.

MEDICLIN ─ a company of the Asklepios Group.



26.09.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-326
Fax: +49 (0)781 488-184
E-mail: alexandra.muehr@mediclin.de
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1450143

 
End of News EQS News Service

1450143  26.09.2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1450143&application_name=news&site_id=boersengefluester_html
Visual performance / price development - MediClin AG
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.